Sponsor:
Aclaris Therapeutics, Inc.
Code:
NCT07935590
Conditions
Lichen Planus
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Modzatinib
Placebo
Brief summary:
Conditions
Lichen Planus
Study ID
NCT07935590
Start date
Nov, 2026
Status verified date
Nov, 2026
Completion date
Apr, 2029
Anticipated
Primary completion date
Mar, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
102 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Oral Erosive Lichen Planus (OLP) Cohort
experimental: Cutaneous Lichen Planus (CLP) Cohort
experimental: Lichen Planopilaris (LPP) Cohort
Interventions
Modzatinib
Placebo
Primary outcome measure
Central contacts
Locations
Aclaris Clinical Site
Recruiting
Savannah, Georgia, United States, 31419
Contacts
Aclaris Clinical Operations
clintrials@aclaristx.comSponsor
Aclaris Therapeutics, Inc.
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Aclaris Therapeutics, Inc. on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.